Torrent pharma successfully completes USFDA inspection for Levittown facility

Published On 2021-12-17 10:58 GMT   |   Update On 2021-12-17 16:47 GMT

Ahmedabad: Torrent Pharma has recently announced that the US Food and Drug Administration (USFDA) has successfully concluded inspection at its Levittown, Pennsylvania, USA manufacturing facility.The inspection was conducted between 6th December 2021 and 15th December 2021."This is to inform that our Levittown, Pennsylvania, USA manufacturing facility was inspected by USFDA between 6 th...

Login or Register to read the full article

Ahmedabad: Torrent Pharma has recently announced that the US Food and Drug Administration (USFDA) has successfully concluded inspection at its Levittown, Pennsylvania, USA manufacturing facility.

The inspection was conducted between 6th December 2021 and 15th December 2021.

"This is to inform that our Levittown, Pennsylvania, USA manufacturing facility was inspected by USFDA between 6 th December 2021 and 15th December 2021,"the company said in a BSE filing.

At the end of the inspection, No Form 483 was issued.

"It is a positive development for the Company and is a reflection of our commitment to consistency in quality and compliance with regulatory standards," the company added.

Read also: Torrent pharma gets CDSCO nod to market additional strength of Amlodipine,Olmesartan Medoxomil FDC

Torrent Pharma is an Indian multinational pharmaceutical company headquartered in Ahmedabad, India. The company specializes in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC).
Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News